Effect of IFN-ß therapy on the frequency and function of CD4+CD25+ regulatory T cells and Foxp3 gene expression in relapsing–remitting multiple sclerosis (RRMS): A preliminary study-Reference-Cited by-同舟云学术

Effect of IFN-ß therapy on the frequency and function of CD4+CD25+ regulatory T cells and Foxp3 gene expression in relapsing–remitting multiple sclerosis (RRMS): A preliminary study

Published:2010-01 Issue:1-2 Volume:218 Page:120-124
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Namdar Afshin,Nikbin Behroz,Ghabaee Mojde,Bayati Asghar,Izad Maryam

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference48 articles.

1. Interferon beta in multiple sclerosis;Arnason;Clin. Immunol. Immunopathol.,1996

2. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation;Asano;J. Exp. Med.,1996

3. Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis;Balandina;Blood,2005

4. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis;Cao;Eur. J. Immunol.,2003

5. Multiple sclerosis and regulatory T cells;Costantino;J. Clin. Immunol.,2008

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases;Nature Reviews Immunology;2024-02-19

2. MicroRNAs are dysregulated in peripheral blood mononuclear cells in multiple sclerosis and correlate with T cell mediators;Journal of Neuroimmunology;2024-01

3. The Effect of the Administration of Interferon and Steroids on Regulatory T-cells in the Liver, Spleen, and Bone Marrow of Mice;Viral Hepatitis Journal;2023-06-09

4. Recent Progress in Multiple Sclerosis Treatment Using Immune Cells as Targets;Pharmaceutics;2023-02-22

5. The immunomodulatory effects of all-trans retinoic acid and docosahexaenoic acid combination treatment on the expression of IL-2, IL-4, T-bet, and GATA3 genes in PBMCs of multiple sclerosis patients;Neurological Research;2023-01-04